Press Releases

ATUM Launches discoCHO™

Quantifying Genetic Stability and Quality Control of Multiple Integrations of Orthogonal Transposases

ATUM Partners with Anagram Therapeutics to Extend Collaboration to Develop Orally Delivered Enzyme Therapies for Malabsorption and Nutrient Metabolism Disorders

ATUM Awarded EcoVadis Silver Medal Rating for its Sustainability Performance

Utilizing AI to Engineer Biologics: From Discovery to Manufacturing, Upcoming Webinar Hosted by Xtalks

ATUM Announces Leap-In Transposase® Licensing Agreement with Codiak Biosciences to Support Manufacturing of Exosome-Based Therapeutics

ATUM Launches cGMP-Compliant Master Cell Bank Production Services

ATUM Partners with TrioBio to Deliver Leap-In Transposase®-Based Bioengineering Solutions to the Chinese Pharmaceutical Market

Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering

IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Serum Institute of India for COVID-19 and Ensure Prompt and Equitable Global Access

Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement for development of robust manufacturing processes for complex therapeutic proteins

ATUM and Phylex BioSciences Collaborate to Accelerate the Development of a Universal SARS Coronavirus Vaccine

Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

ATUM Provides COVID-19 Diagnostic and Therapeutic Developers Free Access to its Protein Synthesis Platform

ATUM Completes Transition to 100% Renewable Electricity for State-of-the-Art Bioproduction Facility

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

ATUM and ADM Extend Joint Development Agreement

ATUM Receives Patent to Expand and Integrate Transposon Based Technologies for Protein Pharmaceutical Development

ATUM and Just Biotherapeutics Team Up to Accelerate Drug Discovery

ATUM and Horizon Discovery Announce Collaboration and Technology Cross-License to Simplify and Speed Bioproduction Cell Line Development

ATUM Signs Patent Licensing Agreement with Thermo Fisher Scientific

DNA2.0 Becomes ATUM

DNA2.0 Leap-In Transposons Protected by Newly Issued U.S. Patent

DNA2.0 Acquires MIGS to Add Antibody Production Capabilities

DNA2.0 Announces Opening of European Office in Basel, Switzerland

DNA2.0 Builds State of the Art Bioproduction Facility in Newark, California

DNA2.0 Announces Issuance of U.S. Patent for Fluorescent and Colored Proteins

ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement

Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc.

DNA2.0 Introduces CRISPR Tools For Genome Engineering

DNA2.0 Partners With St. George’s Infection And Immunity Research Centre On Biopharmaceutical Production In Plants

Protein Variant Library Expertise From DNA2.0

DNA2.0 Patents New DNA Cloning Method

DNA2.0 Partners With Newcastle University On Bacillus Subtillis Expression System

DNA2.0 Teams Up With Penn Gene Therapy Program On Optimizing Gene Expression For HIV-1 Vaccine

DNA2.0 Taps VTU Technology As Research Partner For Industrial Scale Protein Expression

DNA2.0 And Aldevron Collaborate On Insect Cell Expression System

DNA2.0 Sponsors Singularity University Launchpad

DNA2.0 Patents Key Method For Synthesizing Bioplastic Polymer

Press Releases

ATUM Launches discoCHO™

Quantifying Genetic Stability and Quality Control of Multiple Integrations of Orthogonal Transposases

ATUM Partners with Anagram Therapeutics to Extend Collaboration to Develop Orally Delivered Enzyme Therapies for Malabsorption and Nutrient Metabolism Disorders

ATUM Awarded EcoVadis Silver Medal Rating for its Sustainability Performance

Utilizing AI to Engineer Biologics: From Discovery to Manufacturing, Upcoming Webinar Hosted by Xtalks

ATUM Announces Leap-In Transposase® Licensing Agreement with Codiak Biosciences to Support Manufacturing of Exosome-Based Therapeutics

ATUM Launches cGMP-Compliant Master Cell Bank Production Services

ATUM Partners with TrioBio to Deliver Leap-In Transposase®-Based Bioengineering Solutions to the Chinese Pharmaceutical Market

Wheeler Bio Licenses ATUM’s Proprietary Leap-In Transposase® Technology in Support of its Disruptive CDMO Service Offering

IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Serum Institute of India for COVID-19 and Ensure Prompt and Equitable Global Access

Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement for development of robust manufacturing processes for complex therapeutic proteins

ATUM and Phylex BioSciences Collaborate to Accelerate the Development of a Universal SARS Coronavirus Vaccine

Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

ATUM Provides COVID-19 Diagnostic and Therapeutic Developers Free Access to its Protein Synthesis Platform

ATUM Completes Transition to 100% Renewable Electricity for State-of-the-Art Bioproduction Facility

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

ATUM and ADM Extend Joint Development Agreement

ATUM Receives Patent to Expand and Integrate Transposon Based Technologies for Protein Pharmaceutical Development

ATUM and Just Biotherapeutics Team Up to Accelerate Drug Discovery

ATUM and Horizon Discovery Announce Collaboration and Technology Cross-License to Simplify and Speed Bioproduction Cell Line Development

ATUM Signs Patent Licensing Agreement with Thermo Fisher Scientific

DNA2.0 Becomes ATUM

DNA2.0 Leap-In Transposons Protected by Newly Issued U.S. Patent

DNA2.0 Acquires MIGS to Add Antibody Production Capabilities

DNA2.0 Announces Opening of European Office in Basel, Switzerland

DNA2.0 Builds State of the Art Bioproduction Facility in Newark, California

DNA2.0 Announces Issuance of U.S. Patent for Fluorescent and Colored Proteins

ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement

Pareto Biotechnologies Announces Technology Partnership With DNA2.0, Inc.

DNA2.0 Introduces CRISPR Tools For Genome Engineering

DNA2.0 Partners With St. George’s Infection And Immunity Research Centre On Biopharmaceutical Production In Plants

DNA2.0 Introduces Simple, IP-Free©, Scarless Cloning

Protein Variant Library Expertise From DNA2.0

DNA2.0 Patents New DNA Cloning Method

DNA2.0 Partners With Newcastle University On Bacillus Subtillis Expression System

DNA2.0 Teams Up With Penn Gene Therapy Program On Optimizing Gene Expression For HIV-1 Vaccine

DNA2.0 Taps VTU Technology As Research Partner For Industrial Scale Protein Expression

DNA2.0 And Aldevron Collaborate On Insect Cell Expression System

DNA2.0 Sponsors Singularity University Launchpad

DNA2.0 Patents Key Method For Synthesizing Bioplastic Polymer

Search